Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 74
Filter
4.
J Infect Public Health ; 2023 Jun 03.
Article in English | MEDLINE | ID: covidwho-20230655

ABSTRACT

COVID-19 associated severe acute liver injury in a young healthy patient has not been reported much in the literature. And currently, there are no standard management guidelines. We want to report a case of acute liver injury of mixed pattern in a young healthy female with asymptomatic COVID-19 infection. She presented with abdominal pain, nausea, vomiting and yellowish discoloration of her skin. Further laboratory investigations revealed mixed pattern liver injury with highly raised liver enzymes. She was managed with N-acetyl cysteine protocol and monitoring of her liver enzymes. Other causes of acute liver injury were ruled out. She remained stable during her hospital stay and follow up. Our aim is to highlight the significance of acute liver injury in COVID 19 patients that may lead to fatal outcomes if not managed and monitored accordingly.

5.
Trop Med Health ; 51(1): 24, 2023 May 11.
Article in English | MEDLINE | ID: covidwho-2318810

ABSTRACT

Diphtheria, a vaccine-preventable disease, remains a concern in Pakistan as cases have risen post-COVID-19 pandemic causing more than 45 deaths in Pakistan in the year 2022. The respiratory variant of the disease is more common and can lead to serious complications, such as myocarditis and respiratory insufficiency. Diphtheria has caused havoc in the past killing millions of people worldwide before the development of its vaccine. Although the diphtheria toxoid vaccine is effective against toxigenic strains, there have been cases of treatment-resistant strains, particularly the non-toxigenic strains of C. diphtheriae. Pakistan's economic and health systems have suffered setbacks, which have been exacerbated by the COVID-19 pandemic. The pandemic has disrupted routine vaccination programs, and recent floods have contributed to an increase in diphtheria cases and rendered millions homeless. Poor immunization services, inadequate training of vaccination teams, and wealth inequality have all contributed to unequal vaccination coverage in Pakistan. The rising cases of diphtheria call for prompt action, including booster shots, updating vaccination records and administering immediate doses of the toxoid to close contacts.

6.
Front Public Health ; 11: 1078023, 2023.
Article in English | MEDLINE | ID: covidwho-2264080

ABSTRACT

Aim: The study aimed to document the anxiety attributed to COVID-19, disease knowledge, and intention to vaccinate against the disease in general public. Moreover, the interplay among these three outcomes was also investigated. Methods: A cross-sectional study was conducted for 2 months in three cities of Dammam Region of Saudi Arabia. The target segment was the adult population of Saudi Arabia. Convenience sampling was used and all adults aged ≥18 were invited to participate. The questionnaire used in the study was available in both Arabic and English languages. It included a demographic section, a section dedicated to vaccination intention and, a section containing coronavirus anxiety scale (CAS). The data analysis was carried out using IBM SPSS version 23. The study was approved by an ethics committee (IRB-2021-05-297). Results: A total of 542 responses were analyzed. Most respondents had no anxiety attributed to COVID-19 (92.1%), self-reported good knowledge of COVID-19 (79.7%) and intended to administer a vaccine (57.4%). Age groups 18-29 years and 30-45 years, and having a chronic medical condition, were found to be determinants of having COVID-19 anxiety (p < 0.05). The variables of self-rated good knowledge of disease, never contracted COVID-19, and incomes of SAR 5,000 (i.e., USD 1333), and SAR 7,500-10,000 (i.e., USD 1999.5-2666), were found to be determinants of having positive intention toward vaccination (p < 0.05). Conclusion: The anxiety due to COVID-19 was present in a few participants. Besides, self-reported knowledge about COVID-19 and intention to administer a vaccine, were positively linked to each other. However, both variables had no effect on COVID-19 anxiety. It is important to review and address the determinants of positive intention to further increase vaccine acceptance rate.


Subject(s)
COVID-19 , SARS-CoV-2 , Adult , Humans , Saudi Arabia/epidemiology , Cross-Sectional Studies , Intention , COVID-19/epidemiology , COVID-19/prevention & control , Vaccination
7.
J Allergy Clin Immunol Glob ; 2(1): 1-13, 2023 Feb.
Article in English | MEDLINE | ID: covidwho-2266081

ABSTRACT

Novel messenger RNA (mRNA) vaccines have proven to be effective tools against coronavirus disease 2019, and they have changed the course of the pandemic. However, early reports of mRNA vaccine-induced anaphylaxis resulted in public alarm, contributing toward vaccine hesitancy. Although initial reports were concerning for an unusually high rate of anaphylaxis to the mRNA vaccines, the true incidence is likely comparable with other vaccines. These reactions occurred predominantly in young to middle-aged females, and many had a history of allergies. Although initially thought to be triggered by polyethylene glycol (PEG), lack of reproducibility of these reactions with subsequent dosing and absent PEG sensitization point away from an IgE-mediated PEG allergy in most. PEG skin testing has poor posttest probability and should be reserved for evaluating non-vaccine-related PEG allergy without influencing decisions for subsequent mRNA vaccination. Immunization stress-related response can closely mimic vaccine-induced anaphylaxis and warrants consideration as a potential etiology. Current evidence suggests that many individuals who developed anaphylaxis to the first dose of an mRNA vaccine can likely receive a subsequent dose after careful evaluation. The need to understand these reactions mechanistically remains critical because the mRNA platform is rapidly finding its way into other vaccinations and therapeutics.

8.
arxiv; 2023.
Preprint in English | PREPRINT-ARXIV | ID: ppzbmed-2304.12851v1

ABSTRACT

IoT is a fundamental enabling technology for creating smart spaces, which can assist the effective face-to-face and online education systems. The transition to smart education (integrating IoT and AI into the education system) is appealing, which has a concrete impact on learners' engagement, motivation, attendance, and deep learning. Traditional education faces many challenges, including administration, pedagogy, assessment, and classroom supervision. Recent developments in ICT (e.g., IoT, AI and 5G, etc.) have yielded lots of smart solutions for various aspects of life; however, smart solutions are not well integrated into the education system. In particular, the COVID-19 pandemic situation had further emphasized the adoption of new smart solutions in education. This study reviews the related studies and addresses the (i) problems in the traditional education system with possible solutions, (ii) the transition towards smart education, and (iii) research challenges in the transition to smart education (i.e, computational and social resistance). Considering these studies, smart solutions (e.g., smart pedagogy, smart assessment, smart classroom, smart administration, etc.) are introduced to the problems of the traditional system. This exploratory study opens new trends for scholars and the market to integrate ICT, IoT, and AI into smart education.


Subject(s)
COVID-19
9.
Transplantation and Cellular Therapy ; 29(2, Supplement):S311-S312, 2023.
Article in English | ScienceDirect | ID: covidwho-2221550
11.
ssrn; 2022.
Preprint in English | PREPRINT-SSRN | ID: ppzbmed-10.2139.ssrn.4264006

Subject(s)
COVID-19
12.
Pak J Pharm Sci ; 35(4(Special)): 1269-1274, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-2057974

ABSTRACT

People around the globe rumored so many things about the safety and efficacy of initial two doses and booster dose of Covid-19 vaccine, which eventually affected the acceptance of the only tool available against the fight between humans and virus. The aim of current study is to evaluate the acceptance and reluctance level among the population specifically elderly diabetes patients. The cross-sectional study was conducted during a time period of 3 months i.e. from July 2021 until September 2021. A 16-item questionnaire was used to assess the acceptance, reluctance and concerns of the Covid-19 vaccine booster dose among elderly diabetes patients. A 16-item questionnaire was used to assess the acceptance, reluctance and concerns of the Covid-19 vaccine booster dose among elderly diabetes patients. A total of 497 responses were collected and analyzed. Approximately 32% of respondents believed that they need additional information about the Covid-19 vaccine booster dose will be ineffective due to not enough information about the potential side effects of the vaccine dose, while around 80% of respondents showed concerns about safety, efficacy, newness and not enough information about vaccine contents. Around 47.1% of respondents expressed robust concerns about possible side effects of the Covid-19 vaccine booster dose.


Subject(s)
COVID-19 Vaccines , COVID-19 , Diabetes Mellitus , Aged , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Cross-Sectional Studies , Humans , Immunization, Secondary , Pakistan , Vaccines
14.
Transplant Cell Ther ; 28(10): 696.e1-696.e7, 2022 10.
Article in English | MEDLINE | ID: covidwho-1972232

ABSTRACT

Adult hematopoietic stem cell transplantation (HSCT) recipients are at a high risk of adverse outcomes after COVID-19. Although children have had better outcomes after COVID-19 compared to adults, data on risk factors and outcomes of COVID-19 among pediatric HSCT recipients are lacking. We describe outcomes of HSCT recipients who were ≤21 years of age at COVID-19 diagnosis and were reported to the Center for International Blood and Marrow Transplant Research between March 27, 2020, and May 7, 2021. The primary outcome was overall survival after COVID-19 diagnosis. We determined risk factors of COVID-19 as a secondary outcome in a subset of allogeneic HSCT recipients. A total of 167 pediatric HSCT recipients (135 allogeneic; 32 autologous HSCT recipients) were included. Median time from HSCT to COVID-19 was 15 months (interquartile range [IQR] 7-45) for allogeneic HSCT recipients and 16 months (IQR 6-59) for autologous HSCT recipients. Median follow-up from COVID-19 diagnosis was 53 days (range 1-270) and 37 days (1-179) for allogeneic and autologous HSCT recipients, respectively. Although COVID-19 was mild in 87% (n = 146/167), 10% (n = 16/167) of patients required supplemental oxygen or mechanical ventilation. The 45-day overall survival was 95% (95% confidence interval [CI], 90-99) and 90% (74-99) for allogeneic and autologous HSCT recipients, respectively. Cox regression analysis showed that patients with a hematopoietic cell transplant comorbidity index (HCT-CI) score of 1-2 were more likely to be diagnosed with COVID-19 (hazard ratio 1.95; 95% CI, 1.03-3.69, P = .042) compared to those with an HCT-CI of 0. Pediatric and early adolescent and young adult HSCT recipients with pre-HSCT comorbidities were more likely to be diagnosed with COVID-19. Overall mortality, albeit higher than the reported general population estimates, was lower when compared with previously published data focusing on adult HSCT recipients.


Subject(s)
COVID-19 , Hematopoietic Stem Cell Transplantation , Adolescent , COVID-19/epidemiology , COVID-19 Testing , Child , Cohort Studies , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Oxygen , Young Adult
15.
Front Psychol ; 13: 835017, 2022.
Article in English | MEDLINE | ID: covidwho-1952597

ABSTRACT

The COVID-19 pandemic is an unprecedented time in history. Surrounding this pandemic are many enormous uncertainties across the globe. Severe consequences have assessed for the incomes of almost 84% of employers and 68% of self-employed who are working and living in countries that are or have went through a phase of closing workplaces. Similarly, the global rate of unemployment is also expected to be increased in the coming years as 54% of employers worldwide are running their businesses in the hardest-hit sectors. All of these clearly show the uneven impact of the Coronavirus crisis (COVID-19) which will remarkably compound already present inequalities, difficulties, and vulnerabilities. The economic ramifications for 186 countries under the crunch of the COVID-19 pandemic is also considered tremendous for Pakistan. The core aim of this research was to test a new conceptual framework depicting the ramifications of restructuring processes carried out by management for their organizations amidst the COVID-19 pandemic on an Institute's reputation as an employer brand. It also investigates the impact of perceived restructuring on a corporate brand promise made by the university or institute from the viewpoints of other key stakeholders and potential job seekers. The current study had proposed four hypotheses and according to the results of Structural Equation Modeling, the direct hypothesis based upon the relationship between restructuring and employer branding has been rejected. This study shows that restructuring and employer branding has a negative and insignificant effect on each other. The second direct hypothesis of the study that measures the effect of restructuring on corporate branding has been accepted. A corporate brand is a kind of a hub and it considers how an institute treats and deals with all of its stakeholders. It is different from employer brand as the perceptions of employees were the main focus. So, according to the results restructuring did not cause massive damage to the overall outlook of the institute. Furthermore, for the purpose of mediation analysis, the maximum likelihood method by bootstrapping was adopted to test the indirect hypotheses of the study. Crowdsourcing was introduced as a mediator in this study with restructuring, employer, and corporate brand all together in one framework, which is the novel aspect of this study. There are two indirect hypotheses and according to the results both of them did not show any insignificant results. Firstly, the study analyzed mediation among crowdsourcing, restructuring, and employer branding which was fully accepted as the results showed full mediation between these constructs. Secondly, the study analyzed mediation among crowdsourcing, restructuring, and corporate branding which was partially accepted as results showed partial mediation between these constructs.

16.
Results Phys ; 39: 105685, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1946473

ABSTRACT

We proposed a new mathematical model to study the COVID-19 infection in piecewise fractional differential equations. The model was initially designed using the classical differential equations and later we extend it to the fractional case. We consider the infected cases generated at health care and formulate the model first in integer order. We extend the model into Caputo fractional differential equation and study its background mathematical results. We show that the fractional model is locally asymptotically stable when R 0 < 1 at the disease-free case. For R 0 ≤ 1 , we show the global asymptotical stability of the model. We consider the infected cases in Saudi Arabia and determine the parameters of the model. We show that for the real cases, the basic reproduction is R 0 ≈ 1 . 7372 . We further extend the Caputo model into piecewise stochastic fractional differential equations and discuss the procedure for its numerical simulation. Numerical simulations for the Caputo case and piecewise models are shown in detail.

17.
Results Phys ; 39: 105651, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1946470

ABSTRACT

In this paper, we investigate the dynamics of novel coronavirus infection (COVID-19) using a fractional mathematical model in Caputo sense. Based on the spread of COVID-19 virus observed in Algeria, we formulate the model by dividing the infected population into two sub-classes namely the reported and unreported infective individuals. The existence and uniqueness of the model solution are given by using the well-known Picard-Lindelöf approach. The basic reproduction number R 0 is obtained and its value is estimated from the actual cases reported in Algeria. The model equilibriums and their stability analysis are analyzed. The impact of various constant control parameters is depicted for integer and fractional values of α . Further, we perform the sensitivity analysis showing the most sensitive parameters of the model versus R 0 to predict the incidence of the infection in the population. Further, based on the sensitivity analysis, the Caputo model with constant controls is extended to time-dependent variable controls in order obtain a fractional optimal control problem. The associated four time-dependent control variables are considered for the prevention, treatment, testing and vaccination. The fractional optimality condition for the control COVID-19 transmission model is presented. The existence of the Caputo optimal control model is studied and necessary condition for optimality in the Caputo case is derived from Pontryagin's Maximum Principle. Finally, the effectiveness of the proposed control strategies are demonstrated through numerical simulations. The graphical results revealed that the implantation of time-dependent controls significantly reduces the number of infective cases and are useful in mitigating the infection.

18.
BMC Infect Dis ; 21(1): 1014, 2021 Sep 27.
Article in English | MEDLINE | ID: covidwho-1916929

ABSTRACT

BACKGROUND: Convalescent plasma(CP) was utilized as potential therapy during COVID-19 pandemic in Pakistan. The study aimed at appraisal of CP transfusion safety and usefulness in COVID pneumonia. METHODS: Single arm, MEURI study design of non-randomized open label trial was conducted in five centers. Patients werecategorized as moderately severe, severe, and critical. The primary endpoint was a) improvement in clinical status and change in category of disease severity; secondary endpoint was b) CP ability to halt disease progression to invasive ventilation. CP transfused to hospitalized patients. Statistical tests including median (interquartile ranges), Mann-Whitney U test, Fisher's exact test using SPSS ver. 23, ANOVA and Chi-square test were applied for the analysis of results parameters before and after CP treatment. SOFA score was applied for multiorgan failure in severe and critical cases. RESULTS: A total of 50 adult patients; median age 58.5 years (range: 29-92 years) received CP with infusion titers; median 1:320 U/mL (Interquartile range 1:80-1:320) between April 4 to May 5, 2020. The median time from onset of symptoms to enrollment in trial was 3 to 7 days with shortness of breath and lung infiltration as severity criterion. In 35 (70%) recipients, oxygen saturation improved from 80 to 95% within 72h, with resolution of lung infiltrates. Primary endpoint was achieved in 44 (88%) recipients whereas secondary endpoint was achieved in 42 (84%). No patient experienced severe adverse events. A high SOFA score (> 7) correlated with deaths in severe and critical patients. Eight (16%) patients expired due to comorbidities; cardiac arrest in 2 (4%), multiorgan failure secondary to cytokine storm in 5 (10%) and ventilator associated complications in 1 (2%). CONCLUSION: CP transfusion can be used as a safe and useful treatment in moderately severe and severe patients. TRIAL REGISTRATION: The trial registration number is NCT04352751  ( https://www.irct.ir/search/result?query=IRCT20200414047072N1 ). Trial Registration date is 28th April 2020.


Subject(s)
COVID-19 , Pandemics , Adult , Aged , Aged, 80 and over , Blood Component Transfusion , COVID-19/therapy , Humans , Immunization, Passive , Middle Aged , Pakistan , Plasma , SARS-CoV-2 , Treatment Outcome , COVID-19 Serotherapy
19.
Front Cell Infect Microbiol ; 12: 800511, 2022.
Article in English | MEDLINE | ID: covidwho-1911018

ABSTRACT

SARS-CoV-2 is a causative agent for COVID-19 disease, initially reported from Wuhan, China. The infected patients experienced mild to severe symptoms, resulting in several fatalities due to a weak understanding of its pathogenesis, which is the same even to date. This cross-sectional study has been designed on 452 symptomatic mild-to-moderate and severe/critical patients to understand the epidemiology and clinical characteristics of COVID-19 patients with their comorbidities and response to treatment. The mean age of the studied patients was 58 ± 14.42 years, and the overall male to female ratio was 61.7 to 38.2%, respectively. In total, 27.3% of the patients had a history of exposure, and 11.9% had a travel history, while for 60% of patients, the source of infection was unknown. The most prevalent signs and symptoms in ICU patients were dry cough, myalgia, shortness of breath, gastrointestinal discomfort, and abnormal chest X-ray (p < 0.001), along with a high percentage of hypertension (p = 0.007) and chronic obstructive pulmonary disease (p = 0.029) as leading comorbidities. The complete blood count indicators were significantly disturbed in severe patients, while the coagulation profile and D-dimer values were significantly higher in mild-to-moderate (non-ICU) patients (p < 0.001). The serum creatinine (1.22 µmol L-1; p = 0.016) and lactate dehydrogenase (619 µmol L-1; p < 0.001) indicators were significantly high in non-ICU patients, while raised values of total bilirubin (0.91 µmol L-1; p = 0.054), C-reactive protein (84.68 mg L-1; p = 0.001), and ferritin (996.81 mg L-1; p < 0.001) were found in ICU patients. The drug dexamethasone was the leading prescribed and administrated medicine to COVID-19 patients, followed by remdesivir, meropenem, heparin, and tocilizumab, respectively. A characteristic pattern of ground glass opacities, consolidation, and interlobular septal thickening was prominent in severely infected patients. These findings could be used for future research, control, and prevention of SARS-CoV-2-infected patients.


Subject(s)
COVID-19 , SARS-CoV-2 , Adult , Aged , COVID-19/epidemiology , Comorbidity , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Pakistan/epidemiology , Retrospective Studies
20.
Front Public Health ; 10: 847282, 2022.
Article in English | MEDLINE | ID: covidwho-1903207

ABSTRACT

Objective: The study aimed to evaluate the novel coronavirus disease 2019 (COVID-19) vaccination acceptance and reluctance among staff working in Saudi healthcare facilities. Methods: A cross-sectional study was conducted during April - May 2021, among healthcare workers in five public hospitals under the National Guards Health Association located in Alahsa, Dammam, Jeddah, Madinah, and Riyadh. The study used a questionnaire in English language, which was distributed through official email communication among healthcare staff currently working at study venues. The data was analyzed using IBM SPSS v23. An ethical approval was obtained. Results: A total of 1,031 responses were recorded. Most of the staff had both doses of COVID-19 vaccine (89%). The mean score for vaccine acceptance on a scale of 1 (strongly disagree) to 5 (strongly agree) was 3.55 ± 1.6. The mean score for vaccine reluctance on the same scale was 2.71 ± 1.05. Most participants mentioned safety (76.9%) and efficacy (56.3%) as vaccine concerns and believed that COVID-19 vaccine may not be effective because of changes in virus strain (55.5%). The variables of gender and nationality significantly affected vaccine acceptance, while age, gender, nationality, and profession significantly affected vaccine reluctance (p < 0.05). Conclusion: Most healthcare staff were vaccinated, and a high acceptance for COVID-19 vaccination was reported. Several demographic factors affected the vaccine acceptance and reluctance.


Subject(s)
COVID-19 Vaccines , COVID-19 , Attitude of Health Personnel , COVID-19/prevention & control , Cross-Sectional Studies , Health Knowledge, Attitudes, Practice , Humans , Saudi Arabia
SELECTION OF CITATIONS
SEARCH DETAIL